Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Oudkerk M, Sijens PE, Van Beek EJ, Kuijpers TJ. Oudkerk M, et al. Among authors: sijens pe. Invest Radiol. 1995 Feb;30(2):75-8. doi: 10.1097/00004424-199502000-00002. Invest Radiol. 1995. PMID: 7782190 Clinical Trial.
Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.
Sijens PE, Wijrdeman HK, Moerland MA, Bakker CJ, Vermeulen JW, Luyten PR. Sijens PE, et al. Radiology. 1988 Dec;169(3):615-20. doi: 10.1148/radiology.169.3.2847230. Radiology. 1988. PMID: 2847230
1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study.
Sijens PE, Knopp MV, Brunetti A, Wicklow K, Alfano B, Bachert P, Sanders JA, Stillman AE, Kett H, Sauter R, et al. Sijens PE, et al. Magn Reson Med. 1995 Jun;33(6):818-26. doi: 10.1002/mrm.1910330612. Magn Reson Med. 1995. PMID: 7651119
Non-T1-weighted 31P chemical shift imaging of the human liver.
Sijens PE, Van Dijk P, Dagnelie PC, Oudkerk M. Sijens PE, et al. Magn Reson Imaging. 1995;13(4):621-8. doi: 10.1016/0730-725x(95)00005-2. Magn Reson Imaging. 1995. PMID: 7674858
Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma.
Sijens PE, van Dijk P, Oudkerk M. Sijens PE, et al. Magn Reson Med. 1994 Nov;32(5):549-55. doi: 10.1002/mrm.1910320502. Magn Reson Med. 1994. PMID: 7808255
31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF-alpha + melphalan isolated limb perfusion.
Sijens PE, Eggermont AM, van Dijk PV, Oudkerk M. Sijens PE, et al. NMR Biomed. 1995 Aug;8(5):215-24. doi: 10.1002/nbm.1940080506. NMR Biomed. 1995. PMID: 8664107 Clinical Trial.
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
Sijens PE, Vecht CJ, Levendag PC, van Dijk P, Oudkerk M. Sijens PE, et al. Invest Radiol. 1995 Dec;30(12):738-44. doi: 10.1097/00004424-199512000-00008. Invest Radiol. 1995. PMID: 8748188
1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors.
Sijens PE, Levendag PC, Vecht CJ, van Dijk P, Oudkerk M. Sijens PE, et al. NMR Biomed. 1996 Apr;9(2):65-71. doi: 10.1002/(SICI)1099-1492(199604)9:2<65::AID-NBM397>3.0.CO;2-N. NMR Biomed. 1996. PMID: 8887370
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Sijens PE, van den Bent MJ, Nowak PJ, van Dijk P, Oudkerk M. Sijens PE, et al. Magn Reson Med. 1997 Feb;37(2):222-5. doi: 10.1002/mrm.1910370214. Magn Reson Med. 1997. PMID: 9001146
31P magnetic resonance spectroscopy detection of response-predictive adenosine triphosphate decrease in irradiated radiation-induced fibrosarcoma-1 tumors.
Sijens PE, Baldwin NJ, Ng TC. Sijens PE, et al. Invest Radiol. 1997 Jan;32(1):39-43. doi: 10.1097/00004424-199701000-00006. Invest Radiol. 1997. PMID: 9007646
119 results
Jump to page
Feedback